Advertisement

Reactions Weekly

, Volume 1658, Issue 1, pp 132–132 | Cite as

Cladribine/rituximab

Various toxicities: 5 case reports
Case report
  • 39 Downloads

Reference

  1. Wei Z, et al. A single center experience: Rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchialassociated lymphoid tissue lymphoma. Journal of Thoracic Disease 9: 1081-1092, No. 4, Apr 2017. Available from: URL: http://doi.org/10.21037/jtd.2017.03.81 - China

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations